Viewing StudyNCT02151903



Ignite Creation Date: 2024-05-06 @ 2:55 AM
Last Modification Date: 2024-10-26 @ 11:25 AM
Study NCT ID: NCT02151903
Status: TERMINATED
Last Update Posted: 2020-11-27
First Post: 2014-05-23

Brief Title: Open-Label Extension Study of De-immunized DI-Leu16-IL2 Immunocytokine Administered in Participants With B-cell NHL
Sponsor: Alopexx Oncology LLC
Organization: Alopexx Oncology LLC

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-11-04
Start Date Type: ACTUAL
Primary Completion Date: 2016-07-11
Primary Completion Date Type: ACTUAL
Completion Date: 2016-07-11
Completion Date Type: ACTUAL
First Submit Date: 2014-05-23
First Submit QC Date: May 28 2014
Study First Post Date: 2014-06-02
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2020-11-27
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-11-02
Last Update Post Date: 2020-11-27
Last Update Post Date Type: ACTUAL